High-Growth Two-Location Medical Oncology Practice | Southwestern U.S. | Infusion & In-House Pharmacy
Seller Overview:
Seller States: This offering represents the opportunity to acquire a well-established, high-growth medical oncology practice with two locations in separate Southwestern states, each serving a distinct patient population. The primary location has operated for approximately 18 years and includes an in-house pharmacy, infusion suite, and Lab-corp, while the second location was established approximately four years ago to expand into an additional market.
Both offices are fully staffed and operate five days per week, with Nurse Practitioners, Physician Assistants, and Medical Assistants ensuring continuity of care and an uninterrupted service. The practice also maintains an experienced in-house billing team.
The seller, the sole oncologist, currently maintains a progressive clinical schedule across both locations. Significant growth opportunities exist through the future addition of provider, expanded clinic hours, and increased infusion and pharmacy volume.
Revenue is primarily derived from infusion services (~80%), including chemotherapy, and specialty pharmacy with approximately 14% generated from Evaluation & Management visits. Additional revenue streams include in-office procedures such as bone marrow biopsies. The in-house pharmacy operates at both primary locations (inventory not included in the sale).
The practice participates with Medicare and most major commercial insurers, providing a diversified and stable reimbursement base.
Growth Opportunities:
• Expand clinical capacity through additional physicians and/or APPs
• Increase infusion utilization and in-house pharmacy revenue
• Further penetrate two distinct and underserved regional markets
• Addition of imaging services and radiation therapy
Operations & Transition:
• Tenured, experienced clinical and administrative teams in place at both locations
• Established referral relationships and strong reputations in each community
• Efficient, scalable workflows to support a seamless ownership transition
• Seller available for 1–2 years to assist with transition, payer relationships, and growth initiatives
Services Provided:
• Medical oncology
• Hematology
• Chemotherapy and specialty infusions
• Immunotherapy
• Bone marrow biopsies
• Evaluation & Management (E&M) services
• Clinical research (included in this transaction) has increased from four (4) studies in 2025 to eleven (11) in 2026.
Investment Highlights:
• 2025 Gross Revenue of $19M+ with $2.17M+/- SDE & $1.62M+/-Adjusted EBITDA. 2026 is trending substantially higher than 2025.
• Two fully operational, modern facilities in separate Southwestern states
• High-margin, infusion-driven revenue model with ancillary pharmacy income
• Fully staffed, turnkey platform with capacity for provider expansion
• Significant upside through adding a full-time oncologist, expanding clinic hours, and increasing infusion and pharmacy volume
Additional Information:
Serious inquiries only. This medical practice operates in a regulated industry. Prospective buyers should have relevant industry experience and understand the applicable licensing and regulatory requirements.
Execution of a Non-Disclosure Agreement (NDA) and proof of funds are required prior to the release of confidential information.
One Southwest practice location is represented by First Choice Business Brokers Phoenix #213 #101, Dr. Fernando Acosta, Owner/Business Broker/Agent (AZ R.E. Lic.# LC68988001 | SA691260000) and Dr. Leilani Felix- Acosta, Owner/Business Broker (AZ R.E. Lic. #LC68988001 | SA693611000. The other Southwest practice location is represented by a separate licensed brokerage in that state.
Listing Number:
Category:
Location:
SOLD
Financial Information:
Gross Revenue:
Listed Price:
Total Adjusted Net Income:
Equipment / Fixtures:
Year Established:
General Location:
Hello World
First Choice Business Brokers
The information contained herein was received from the Seller and is deemed reliable but not guaranteed. First Choice Business Brokers (FCBB), has relied upon the Seller to provide the above details and has NOT verified this information. FCBB is not responsible for and does NOT warrant any statements, projections or any information provided by the Seller. The User/Buyer will be solely responsible for verification of the Seller's profits and business operation. By acceptance of this document, the Buyer/User agrees that all information contained herein is strictly confidential and will not be disclosed to any other party without prior written authorization. The Buyer/User confirms and understands that FCBB has NOT performed an independent investigation of the business or figures quoted herein.
FCBB strongly recommends that a Buyer should seek legal and accounting advice prior to purchasing a Business. Any change to the above information requires both the Seller's and FCBB's written approval. Any change made to this document without FCBB and Seller approval is not valid.
The information in this listing has been provided by the business seller or representative stated above. First Choice Business Broker has no stake in the sale of this business, has not independently verified any of the information about the business, and assumes no responsibility for its accuracy or completeness.
Read First Choice Business Broker, Terms of Use before responding to any ad.
Confidential 2-Location Oncology / Hematology Medical Practice
Location: Southwest Region, U.S.A.
High-Growth Two-Location Medical Oncology Practice | Southwestern U.S. | Infusion & In-House Pharmacy
Seller Overview:
Seller States: This offering represents the opportunity to acquire a well-established, high-growth medical oncology practice with two locations in separate Southwestern states, each serving a distinct patient population. The primary location has operated for approximately 18 years and includes an in-house pharmacy, infusion suite, and Lab-corp, while the second location was established approximately four years ago to expand into an additional market.
Both offices are fully staffed and operate five days per week, with Nurse Practitioners, Physician Assistants, and Medical Assistants ensuring continuity of care and an uninterrupted service. The practice also maintains an experienced in-house billing team.
The seller, the sole oncologist, currently maintains a progressive clinical schedule across both locations. Significant growth opportunities exist through the future addition of provider, expanded clinic hours, and increased infusion and pharmacy volume.
Revenue is primarily derived from infusion services (~80%), including chemotherapy, and specialty pharmacy with approximately 14% generated from Evaluation & Management visits. Additional revenue streams include in-office procedures such as bone marrow biopsies. The in-house pharmacy operates at both primary locations (inventory not included in the sale).
The practice participates with Medicare and most major commercial insurers, providing a diversified and stable reimbursement base.
Growth Opportunities:
• Expand clinical capacity through additional physicians and/or APPs
• Increase infusion utilization and in-house pharmacy revenue
• Further penetrate two distinct and underserved regional markets
• Addition of imaging services and radiation therapy
Operations & Transition:
• Tenured, experienced clinical and administrative teams in place at both locations
• Established referral relationships and strong reputations in each community
• Efficient, scalable workflows to support a seamless ownership transition
• Seller available for 1–2 years to assist with transition, payer relationships, and growth initiatives
Services Provided:
• Medical oncology
• Hematology
• Chemotherapy and specialty infusions
• Immunotherapy
• Bone marrow biopsies
• Evaluation & Management (E&M) services
• Clinical research (included in this transaction) has increased from four (4) studies in 2025 to eleven (11) in 2026.
Investment Highlights:
• 2025 Gross Revenue of $19M+ with $2.17M+/- SDE & $1.62M+/-Adjusted EBITDA. 2026 is trending substantially higher than 2025.
• Two fully operational, modern facilities in separate Southwestern states
• High-margin, infusion-driven revenue model with ancillary pharmacy income
• Fully staffed, turnkey platform with capacity for provider expansion
• Significant upside through adding a full-time oncologist, expanding clinic hours, and increasing infusion and pharmacy volume
Additional Information:
Serious inquiries only. This medical practice operates in a regulated industry. Prospective buyers should have relevant industry experience and understand the applicable licensing and regulatory requirements.
Execution of a Non-Disclosure Agreement (NDA) and proof of funds are required prior to the release of confidential information.
One Southwest practice location is represented by First Choice Business Brokers Phoenix #213 #101, Dr. Fernando Acosta, Owner/Business Broker/Agent (AZ R.E. Lic.# LC68988001 | SA691260000) and Dr. Leilani Felix- Acosta, Owner/Business Broker (AZ R.E. Lic. #LC68988001 | SA693611000. The other Southwest practice location is represented by a separate licensed brokerage in that state.
Listing Number:
Category:
Location:
Southwest Region, U.S.A.
Ciro 'Vic' Coppola
Office: (702) 368-2500 | Cell: (725) 233-3333
License #: BS.0146004
Financial Information:
Gross Revenue
$19,315,198
Listed Price:
$10,000,000
Lease Information:
Square Feet:
3995
Total Rent:
$8,980
Lease Expiration:
04/2029
Lease Options:
2 / 5 years
Asset Information:
Leasehold Improvements:
$0
Equipment / Fixtures:
$0
Additional Information:
Full-Time Employees:
12
Part-Time Employees:
0
Training Period:
TBD. Willing to stay 1-2 years
Reason for Selling:
N/A
First Choice Business Brokers
The information contained herein was received from the Seller and is deemed reliable but not guaranteed. First Choice Business Brokers (FCBB), has relied upon the Seller to provide the above details and has NOT verified this information. FCBB is not responsible for and does NOT warrant any statements, projections or any information provided by the Seller. The User/Buyer will be solely responsible for verification of the Seller's profits and business operation. By acceptance of this document, the Buyer/User agrees that all information contained herein is strictly confidential and will not be disclosed to any other party without prior written authorization. The Buyer/User confirms and understands that FCBB has NOT performed an independent investigation of the business or figures quoted herein.
FCBB strongly recommends that a Buyer should seek legal and accounting advice prior to purchasing a Business. Any change to the above information requires both the Seller's and FCBB's written approval. Any change made to this document without FCBB and Seller approval is not valid.
The information in this listing has been provided by the business seller or representative stated above. First Choice Business Broker has no stake in the sale of this business, has not independently verified any of the information about the business, and assumes no responsibility for its accuracy or completeness.
Read First Choice Business Broker,
Terms of Use before responding to any ad.
